NDRA - Total Utang marang Modal ENDRA Corp

ENDRA Life Sciences (NDRA) bases its expansion on the development of unique ultrasound software and sensors, ensuring high profitability upon mass clinical adoption. The innovative TAEUS method enables the precise detection of steatosis without the need for expensive MRI, streamlining the screening process. This chart of share price dynamics, where the debt-to-equity ratio stands at 0.07, highlights the company's urgency to capture the niche before major medtech behemoths enter the market.

The leverage ratio measures the proportion of debt obligations relative to equity, allowing investors to assess financial leverage and bankruptcy risk in the event of a decline in asset values. By analyzing the current total debt-to-equity ratio, one can determine the extent to which the stable core of engineers and developers at ENDRA Life Sciences (NDRA) is supported by a resilient balance sheet structure without excessive pressure from creditors.